Details of the Drug Formulations

General Information of Drug (ID: DMHT34O)

• Drug Name: Gemifloxacin Drug Info
• Synonyms: Factiv; Factive; Gemifloxacin [INN]; Gemifloxacin mesilate; LB 20304; LB 20304a; SB 265805; Factiv (TN); Factive (TN); Gemifloxacin (INN); LB-20304; SB-265805; 7-(3-Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid; 7-(3-Aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid; 7-[3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid

Indication

Disease Entry	ICD 11	Status	REF
Bacterial infection	1A00-1C4Z	Approved	[1]
Mycoplasma pneumoniae pneumonia		Approved	[2]
Streptococcal pneumonia		Approved	[2]
Pneumonia caused by chlamydia		Investigative	[2]
Pneumonia due to Klebsiella pneumoniae	CA40.03	Investigative	[2]

• Therapeutic Class: Antibiotics
• Cross-matching ID:
  PubChem CID: 9571107
  ChEBI ID: CHEBI:101853
  CAS Number: 175463-14-6
  TTD ID: D0VR7W
  VARIDT ID: DR00688
  ACDINA ID: D00301

Full List of Drug Formulations Containing This Drug

Gemifloxacin 320 mg tablet

Company	Formulation ID	FDA Description
Cornerstone Therapeutics; Merus Labs International; Vansen Pharma	F09117	Magnesium stearate; Titanium dioxide; Crospovidone; Polyethylene glycol 4000; Polyethylene glycol 6000; Povidone; Cellulose, microcrystalline; Hypromellose 2910 (15 mpa.s); Hypromellose 2910 (5 mpa.s)

References

• [1] Emerging drugs for bacterial urinary tract infections. Expert Opin Emerg Drugs. 2005 May;10(2):275-98.
• [2] Gemifloxacin FDA Label